This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by CASPER, R. F. Articles by POWELL, A.-M. Search for Related Content PubMed PubMed Citation Articles by CASPER, R. F. Articles by POWELL, A.-M.

Thyrotropin and Prolactin Responses to Thyrotropin-Releasing Hormone in Premenstrual Syndrome^*

Medical Research Council Group in Reproductive Biology and the Department of Obstetrics and Gynecology, University of Western Ontario London, Ontario, Canada

Address all correspondence and requests for reprints to: Dr. R. F. Casper, Reproductive Biology Unit, 6th floor, Eaton Wing, Toronto General Hospital, Toronto, Ontario, Canada M5G 2C4.

Recent reports of altered TSH responsiveness t o its releasing hormone (TRH) in women with premenstrual syndrome (PMS) suggested that subclinical hypothyroidism may be responsible for the mood changes, such as depression, that occur in these women. In this study we measured basal and TRH-stimulated serum TSH and PRL levels in 15 women with PMS and in 19 age-matched normal women. The mean baseline serum TSH concentrations were similar in the 2 groups in both the follicular [normal, 1.3 ± 0.2 (±SE); PMS, 0.9 ± 0.2 mU/L] and luteal (normal, 1.1 ± 0.2; PMS, 1.1 ± 0.2 mU/L) phases of the cycle. The mean baseline serum PRL levels also were similar in the 2 groups in the follicular (normal, 16 ± 2; PMS, 13 ± 2 µg/L) and luteal (normal, 13 ± 2; PMS, 14 ± 2 µg/L) phases of the cycle. After TRH administration, peak serum PRL and TSH levels were reached at 15 and 30 min, respectively, and the response curves were virtually identical in the 2 groups in both phases of the cycle. One normal woman had elevated basal and TRH-stimulated TSH concentrations compatible with subclinical hypothyroidism, but had normal noncyclic scores on her prospective rating scales. Our findings suggest that PMS is not associated with thyroid dysfunction or abnormal PRL secretion and that thyroid hormone replacement therapy is not indicated in this condition.

^* This work was supported by the Medical Research Council of Canada.

Received August 16, 1988.

This article has been cited by other articles:

				S. S. Girdler, K. S. Thompson, K. C. Light, J. Leserman, C. A. Pedersen, and A. J. Prange Jr. Historical Sexual Abuse and Current Thyroid Axis Profiles in Women With Premenstrual Dysphoric Disorder Psychosom Med, May 1, 2004; 66(3): 403 - 410. [Abstract] [Full Text] [PDF]

				E. Leibenluft, P. L. Fiero, and D. R. Rubinow Effects of the Menstrual Cycle on Dependent Variables in Mood Disorder Research Arch Gen Psychiatry, October 1, 1994; 51(10): 761 - 781. [Abstract] [PDF]

				N.R. Best, M.P. Rees, D.H. Barlow, and P.J. Cowen Effect of oestradiol treatment on 5-HT and dopamine-mediated neuroendocrine responses J Psychopharmacol, January 1, 1992; 6(4): 483 - 488. [Abstract] [PDF]